Surveillance For Adverse Events After COVID-19 Mrna Vaccination

This journal article addresses safety concerns related to the administration of COVID-19 mRNA vaccines. It also discusses surveillance procedure and coordination of data collection and analysis capacity for public safety.

Related Topics

Disease Tracking and Surveillance

Disease surveillance helps us detect disease cases, understand burden of disease and risk factors, provide the basis for timely and informed decision-making, guide control measures, and monitor impacts. Since the onset of COVID-19, surveillance efforts have worked to provide real-time tracking and forecast data, despite challenges with diagnostic capacity, case reporting, insufficient contact tracing, and fragmented data systems. COVID-19 has highlighted the need to invest in modern data systems, expand and skill up the workforce, and ensure data reporting and interpretation retain high ethical and epidemiological standards.